A new drug for Type 2 diabetes launched in the UK could save the NHS £70 million over the next five years, according to its manufacturer.
Lixisenatide, marketed under the name Lyxumia, is self-administered once a day using an injection pen.
The drug acts on a naturally occurring hormone called...